MarketCap
Facebook
X
TelegramAnnual report 2024
added 04-25-2026
Medigus Ltd. EPS Ratio 2011-2026 | MDGS
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Medigus Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 0.01 | -0.03 | -0.18 | -0.16 | -0.2 | -2.62 | -0.34 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.01 | -2.62 | -0.503 |
Quarterly EPS Ratio Medigus Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.06 | - | - | - | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.06 | -0.06 | 0 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
0.89 | $ 25.3 | 0.8 % | $ 214 M |  USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 2.0 | 0.76 % | $ 1.22 M | USA |
 |
IRIDEX Corporation
IRIX
|
-0.26 | $ 1.04 | 0.72 % | $ 17.6 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 12.96 | -0.84 % | $ 1.75 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 14.75 | 0.75 % | $ 346 M | USA |
 |
LivaNova PLC
LIVN
|
-4.45 | $ 58.86 | -0.1 % | $ 3.21 B |  Britain |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.35 | 1.06 % | $ 125 M |  France |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
PAVmed
PAVM
|
-5.63 | $ 8.54 | -4.32 % | $ 5.73 M | USA |
 |
Insulet Corporation
PODD
|
3.51 | $ 167.15 | 4.46 % | $ 11.8 B | USA |
 |
BioSig Technologies
BSGM
|
-9.65 | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 10.44 | 0.97 % | $ 296 M | USA |
 |
Sintx Technologies
SINT
|
-6.16 | $ 2.07 | 4.02 % | $ 5.74 M | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.13 | $ 0.63 | -1.29 % | $ 39.2 M | USA |
 |
Stryker Corporation
SYK
|
2.21 | $ 316.51 | 0.49 % | $ 121 B | USA |
 |
Tactile Systems Technology
TCMD
|
0.83 | $ 22.36 | -0.62 % | $ 511 M | USA |
 |
TELA Bio
TELA
|
-0.83 | $ 0.94 | 9.29 % | $ 44.1 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-0.01 | $ 18.53 | 2.04 % | $ 1.26 B | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
Varex Imaging Corporation
VREX
|
-1.7 | $ 11.38 | 3.13 % | $ 471 M | USA |
 |
Vivos Therapeutics
VVOS
|
-2.07 | $ 0.83 | 6.36 % | $ 8.53 M | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 4.55 | -7.52 % | $ 963 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
3.98 | $ 88.88 | 1.24 % | $ 12 B | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 10.28 | 0.69 % | $ 368 M | USA |
 |
CONMED Corporation
CNMD
|
1.52 | $ 37.15 | 3.31 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
4.95 | $ 53.58 | 0.32 % | $ 1.57 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.96 | $ 85.0 | 1.59 % | $ 2.95 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.84 | $ 81.56 | 0.43 % | $ 47.7 B | USA |
 |
Invacare Corporation
IVC
|
-0.54 | - | - | $ 24.7 M | USA |